Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24901112 | 0.91 | DUSP3 (0.32) | HPGDSMN1; SMN2ALDH1A1MEN1THRB | |
| SCHEMBL24901334 | 0.91 | DUSP3 (0.33) | CA12CA1CA2CA9HPGD | |
| SCHEMBL24901320 | 0.91 | DUSP3 (0.33) | CA12CA1CA2CA9HPGD | |
| SCHEMBL24901338 | 0.90 | DUSP3 (0.32) | HPGDSMN1; SMN2ALDH1A1MEN1THRB | |
| SCHEMBL24901339 | 0.89 | AKR1C3 (0.35) | DUSP3 | |
| SCHEMBL24901211 | 0.89 | HPGD (0.32) | CA12CA1CA2CA9HPGD | |
| SCHEMBL24901118 | 0.88 | AHR (0.33) | HPGDRAB9AMAOBALDH1A1MEN1 | |
| SCHEMBL24901270 | 0.87 | AHR (0.32) | HPGDRAB9AMAOBALDH1A1MEN1 | |
| SCHEMBL24901333 | 0.87 | ALOX5 (0.37) | — | |
| SCHEMBL26588742 | 0.85 | DUSP3 (0.34) | HPGDRAB9ASMN1; SMN2MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012692-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012692-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | MAOA, SAT1, ALDH1A1 | CA12 3821/4885CA1 3423/4885CA2 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.